Laurent Pharmaceuticals: Laurent gets FDA approval to expand Phase II Covid-19 oral antiviral trial

Laurent Pharmaceuticals: Laurent Pharmaceuticals Extends COVID-19 Phase 2 Study with Oral Antiviral LAU-7b that has Showed 100% Reduction in the Risk of Progression onto Mechanical Ventilation and Death

Laurent Pharmaceuticals: Laurent Pharmaceuticals Extends COVID-19 Phase 2 Study with Oral Antiviral LAU-7b that has Showed 100% Reduction in the Risk of Progression onto Mechanical Ventilation and Death

Laurent Pharmaceuticals: Laurent Pharmaceuticals Announces Topline Results from its Phase 2 RESOLUTION Clinical Trial of LAU-7b for the Treatment of COVID-19

Press Release: Laurent Pharmaceuticals : Laurent Pharmaceuticals Completes Patients Enrollment in Phase 2 Study of LAU-7b for the Treatment of COVID-19

Laurent Pharmaceuticals: Laurent to continue study of LAU-7b in Covid-19 patients

Press Release: Laurent Pharmaceuticals : Laurent Pharmaceuticals Provides Clinical Development Update